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Abstract
Background: Despite the potential impact on treatment adherence and recovery, there is a dearth of data on the
extent and correlates of internalized stigma in patients with schizophrenia in low income countries. We conducted
a study to determine the extent, domains and correlates of internalized stigma amongst outpatients with
schizophrenia in Ethiopia.
Methods: The study was a cross-sectional facility-based survey conducted at a specialist psychiatric hospital in
Addis Ababa, Ethiopia. Consecutive consenting individuals with a diagnosis of schizophrenia were recruited and
assessed using an Amharic version of the Internalized Stigma of Mental Illness (ISMI) scale.
Results: Data were collected from 212 individuals, who were mostly single (71.2%), unemployed (70.3%) and male
(65.1%). Nearly all participants (97.4%) expressed agreement to at least one stigma item contained in the ISMI;
46.7% had a moderate to high mean stigma score. Rural residence (OR = 5.67; 95% CI = 2.30, 13.00; p < 0.001), single
marital status (OR = 3.39; 95% CI = 1.40, 8.22; p = 0.019) and having prominent psychotic symptoms (OR = 2.33; 95%
CI = 1.17, 4.61; p = 0.016) were associated independently with a higher stigma score. Almost half of those who
discontinued their treatment reported that they had done so because of perceived stigma. Those who had
attempted suicide (45.3%) were more likely to have a high stigma score (OR = 2.29; 95% CI = 1.27, 4.11; p = 0.006).
Over 60% of the variation in the experience of stigma was explained by four factors: social withdrawal (16.7%),
perceived discrimination (14.1%), alienation (13.9%) and stereotype endorsement (12.7%).
Conclusion: Internalized stigma is a major problem among persons with schizophrenia in this outpatient setting in
Ethiopia. Internalized stigma has the potential to substantially affect adherence to medication and is likely to affect
the recovery process.
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Background
Whilst most mental illnesses may be associated with
some degree of stigma, schizophrenia has been described
as “a modern day equivalent of leprosy”, conferring
unparalleled social ostracism to the person with schizo-
phrenia and their family [1]. Stigma comprises of three
elements: problems of knowledge (misinformation), pro-
blems of attitudes (prejudice), and problems of behaviour
(discrimination) [2].
Furthermore, two major classes of stigma are recog-
nized: public stigma and personal stigma. Public stigma
(or social stigma) typically describes the endorsement
of stereotypes and enacted behaviours against people
with mental illness by professionals and the general
population [2,3]. Personal experiences of stigma, mea-
sured in those with mental illness, can be considered in
three ways [3]:
(i) Perceived stigma: what the individual thinks are
society’s beliefs about the stigmatized group
(ii) Experienced stigma: actual discrimination
experienced
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(iii) Self-stigma: a product of the internalization of
public stigma
In internalized stigma or self-stigma, a gradual process
of psychological assimilation of the public stereotypes to-
wards mental illness is said to occur such that the person
with mental illness progressively loses what they think
they are and wish to be in the future [4]. In essence, the
person not only believes that others think s/he is not
worthwhile or should not, for example be married, but
also believes that s/he is not actually worth much and
should not be married. This changes fundamentally the
perception the person has about themselves and leads to a
change in the person’s behaviour in a way that matches
the internalized perceptions. Until recently most research
has focused on public stigma rather than internalized
stigma [2]. Several studies have emphasized the negative
consequences of such negative perceptions and behaviour,
including loss of self-esteem and self-efficacy, disem-
powerment, demoralization and loss of income [5-8].
Clinically, higher depressive symptoms, increased suicidal-
ity and poorer medication adherence are also reported [9].
Because of the above consequences and related negative
impacts such as social withdrawal, poor vocational func-
tioning and worse quality of life [5-7,9-14], internalized
stigma is emerging as a key factor that can hold back the
recovery process.
Stigma is a major problem across different societies,
but the particular manifestations of stigma may vary.
Variation in the interaction between stigma and mental
illness is evident in different settings [15]. Stigma is also
considered an important explanatory factor for the better
outcome of schizophrenia in low income settings [16].
Families in developing societies have been described as
“supportive and tolerant” and that there is “little risk of
prolonged rejection, isolation, segregation and institutio-
nalisation” [17]. In the developed societies that emphasize
individuality, it is proposed that loss of employment would
mean loss of status and self-esteem and rejection. The
person with the illness takes responsibility for the illness
and its consequences. Although these principles are rele-
vant, making broad generalizations cannot always hold
true. For example, in cultures where stigma is considered
to be a moral issue, it may threaten what “matters most”
for those living in the local world [18,19]. Moreover, if the
proposition about persons from low income setting taking
less individual responsibility is correct, this is likely to be
replaced by the responsibility they feel for their family.
Thus a person from low income settings would feel re-
sponsible for the consequences of the illness on the family
experiencing the illness not only as a personal tragedy but
that they have caused disgrace to the family by becoming
ill, and that the condition may have devastating conse-
quences on the social standing of the family. Although our
study has not explored these broader cultural issues, we
consider that the level of stigma is likely to reflect the
broader personal and family implications of having a men-
tal illness.
Most of our understanding about internalized stigma
originates from high-income countries. Yet the few avail-
able studies have demonstrated high levels of internalized
stigma amongst patients with schizophrenia in some
African countries: Ghana [20], Nigeria [21] and South
Africa [22]. There has been no previous assessment of
internalized stigma in Ethiopia. The only reported study
concerning stigma in severe mental disorders in Ethiopia
looked at perceived stigma among 178 carers of persons
with schizophrenia and major affective disorders [23].
This study was part of a large community-based project
in Southern Ethiopia [24]. About 75% of the caregivers
reported experiencing stigma. Urban residence and older
age were the main factors associated with higher experi-
ence of stigma. The finding suggests that the experience
of internalized stigma may also be high [23].
Systematic investigation of the extent and correlates of
internalized stigma is an essential part of planning for re-
covery programs for schizophrenia. This research is timely
for the Ethiopian setting and other low-income country
settings as mental health services are undergoing a shift
towards primary health care and community settings [25].
Community-based rehabilitation (CBR) for people with
schizophrenia, including social and vocational rehabilita-
tion, will form part of the services under development. An
understanding of the stigma and discrimination experi-
enced by this group is vital to developing appropriate
training materials for the community health workers who
will deliver the CBR. Anti-stigma campaigns are gaining
prominence in high-income countries [26]. For low-
income countries to follow suit a more detailed under-
standing of the extent and nature of the stigma related to
mental illness is required. This will also allow evaluation
of the effectiveness of anti-stigma campaigns.
Objectives
The primary objective of the study was to assess the
extent of internalized stigma among patients with
schizophrenia attending the outpatient department of a
psychiatric hospital in Ethiopia. Related to this we aimed
to determine which socio-demographic and clinical fac-
tors are associated with the experience of stigma and to
explore the potential impact of stigma on medication
adherence and risk behaviour; important factors that
may affect the recovery process.
Methods
Study design and setting
The study was a facility-based cross-sectional survey
conducted at a psychiatric hospital located in the capital
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city, Addis Ababa. The hospital is the oldest and largest
public psychiatric hospital in Ethiopia. Patients from all
over the country come to the hospital to receive treat-
ment for severe mental disorders. The hospital service is
organized under specialist programs or specialist case
teams. Each case team is expected to have expert know-
ledge about the disorders it treats. Patients with schizo-
phrenia are treated by psychoses case teams and this
case team manages all individuals with schizophrenia
referred or seen by the hospital. The hospital has an
inpatient service with 280 bed and a large out-patient
service, with around 115,000 outpatients visiting the
hospital each year.
Participants
Participants of this study were patients with a clinical
diagnosis of schizophrenia, aged 18 years and above. Po-
tential participants were selected by reviewing the medical
records of patients attending regular follow-up appoint-
ments. Individuals with clinically established impairment
of insight, a significant level of cognitive impairment or
significant level of substance abuse in the previous three
months were excluded based on a review of clinical
records and clinical assessment by senior psychiatric resi-
dents. We focused on schizophrenia in order to have a
relatively uniform group of participants. Individuals with
substance abuse were excluded because of the potential
impact of substance abuse on the experience of stigma.
Assessment
The Internalized Stigma of Mental Illness (ISMI) Scale
for the assessment of stigma [27] was translated into
Amharic, the official language of Ethiopia. The ISMI
scale is a widely used instrument consisting of 29 items,
which have been grouped into five domains: alienation,
stereotype endorsement, social withdrawal, perceived
discrimination and stigma-resistance. The 29-item ISMI,
and four of the five domains, have good levels of internal
consistency and test-retest reliability [27]. However, the
fifth subscale (stigma-resistance subscale) is conceptually
different from the other parts of the scale and has lower
internal consistency [28,29]. This subscale was therefore
not used in our study. The 24-item ISMI is reported to
have excellent internal consistency with an alpha of 0.91
and a test–retest correlation of 0.73 [27]. Each ISMI
item contains a declarative statement about a potential
stigma issue and participants respond to each statement
by indicating their level of agreement: 1 = strongly dis-
agree; 2 = disagree; 3 = agree; 4 = strongly agree.
In addition to the ISMI, participants were asked sim-
ple questions in relation to whether they experienced
stigma within their family, in the neighbourhood and
whether they felt disrespected by the mental health staff
because of their illness.
Furthermore, we asked two questions on medication
adherence and one on suicide attempts. The medication
adherence question asked about history of non-adherence
with psychotropic medications and whether the non-
adherence behaviour was linked to stigma. Specifically we
asked “Have you ever discontinued medication”? and “Did
your experience of stigma contribute to your decision to
discontinuing medication?”. The question on suicide sim-
ply asked whether the participant had felt so desperate
that they had attempted suicide (“Have you ever felt so
desperate that you even attempted to harm yourself or
end your life?”). This question is similar to the single ques-
tion used in asking about suicide attempt in the widely
used structured diagnostic interview instrument of the
World Health Organization, the Composite International
Diagnostic Interview [30]. The occurrence of positive and
negative symptoms was assessed using a checklist from
the Diagnostic and Statistical Manual of Mental Disorders,
Fourth edition (DSM-IV) [31] while the presence of extra-
pyramidal symptoms was assessed clinically.
Instrument adaptation procedure
The 24-item ISMI scale, which has been validated and
used in an outpatient setting for patients with schizo-
phrenia [27], was translated and used in our study. After
producing three independent Amharic versions by three
senior psychiatry residents and a senior psychiatrist, a
consensus version was developed in a group discussion
involving two other senior psychiatrists. The consensus
version was back-translated by a consultant psychiatrist.
This was compared with the original consensus version,
which required only minor modifications. Inter-rater
reliability assessment was completed by the four psych-
iatry residents who participated in the administration of
the instrument. The inter-rater agreement was good
(Kappa = 0.76). The Cronbach’s alpha based on standar-
dised items was also good (0.92). Before the study a pilot
exercise was undertaken and necessary modifications
were made.
Administration of instruments
After inclusion criteria were met, all instruments were
administered in the local language (Amharic) by senior
psychiatric residents. Although the ISMI is self-
administered instrument, the ISMI questions were dir-
ectly asked by the residents. Because of the variable
level of literacy it was deemed necessary to use inter-
viewers who read the questions to the participants.
Data analysis
Analyses were performed using SPSS version 17 and
Stata version 11. Most predictive variables were categor-
ized a priori. Age was also categorized into ten-year
intervals before analysis was run in order to determine
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which age group, if any, would be more affected by the
experience of internalized stigma. Mean scores for each
ISMI item and domains, as well as the overall ISMI,
were computed following the standard analytic methods
for internalized stigma used in previous studies [32]. We
extracted data from a European study [32] as a compari-
son for our findings. A binary logistic regression model
was used to determine the association of selected socio-
demographic and clinical factors with higher internalized
stigma experience using the mean internalized stigma
score as a cut off. Furthermore, for each ISMI item we cal-
culated the proportion reporting ‘Any stigma’ (a response
of “agree” or “strongly agree” on any stigma item) and
‘Strong stigma’ (a response of “strongly agree” only).
Finally, exploratory factor analysis was completed using
principal component analysis and varimax rotation to de-
termine how the variability in the experience of interna-
lized stigma might be explained. This method was
preferred to a confirmatory factor analysis method be-
cause of the lack of previous studies in Ethiopia using the
ISMI.
Ethical considerations
The study proposal was initially approved by the scien-
tific committee of the Department of Psychiatry, School
of Medicine, College of Health Sciences, Addis Ababa
University. Amanuel Hospital Ethics Committee granted
further ethical approval. Informed consent was sought
from each participant.
Results
Socio-demographic and clinical characteristics
There were 212 participants, the majority of whom were
males (65.1%) and from urban areas (79.7%). The mean
age of the participants was 33.3 years (SD 8.9). Nearly
three-quarters (70.3%) were unemployed although most
had some level of education, and 20.8% were college
graduates. Only 25.9% were married (Table 1), with over
half dependent on their family. Most of the participants
had indications of severe illness (Table 2): 45.3% had
attempted suicide at least once since the onset of their
illness; 67.5% had a history of admission; and 55.7% had
noticeable extra-pyramidal side effects. During the as-
sessment 32.1% of the participants had uncontrolled
psychotic symptoms; with either prominent positive or
negative symptoms or a combination of these. Nearly
two-thirds (60.4%) of participants admitted discontinu-
ing their treatment. Sixty two percent of those who dis-
continued treatment attributed this to internalized
stigma related to their illness.
ISMI Factor domains
Basic standards for conducting factor analysis were met.
The Kaiser-Meyer-Olkin measure of sampling adequacy
was 0.903, well above the recommended minimum of 0.6,
and Bartlett’s test of sphericity was significant (χ2 (276) =
2496.0, p < 0.001). Finally, the communalities were all
above 0.43. Only factors with Eigen values of one or above
were included. Four factors were identified from the factor
analysis: social withdrawal, perceived discrimination,
alienation and stereotype endorsement. These factors
explained 61.9% of the total variance: social withdrawal
16.7%, perceived discrimination 14.1%, alienation 37.9%
and stereotype endorsement 12.4% (Table 3).
Prevalence of internalized stigma
Overall 97.4% of participants reported experiencing at
least one internalized stigma item at the time of the
interview. Nearly three-quarters of respondents (71%)
expressed strong agreement to at least one internalized
stigma item (Figure 1). Some patients experienced
stigma within the family (24.5%) and neighborhood
(17%). Occasional disrespect from mental health staff
was reported by 31.6% of the participants. The overall
mean internalized stigma score across all four domains
was between 2.3 and 2.5 and comparison with data
from the above European study indicates clear similar-
ity (Table 4) in the experience of internalized stigma.
Table 1 Socio-demographic characteristics of participants
Variable Total
N %
Total –––––– 212 100
Sex Male 138 65.1
Female 74 34.9
Age (years) <25 30 14.2
25-34 89 42.0
35-44 70 33.0
≥45 23 10.8
Residence Urban 169 79.7
Rural 43 20.3
Employment Employed 63 29.7
Unemployed 149 70.3
Ethnicity Amhara 85 40.1
Oromo 50 23.6
Gurage 52 24.5
Others 25 11.8
Educational level Non-literate 19 9.0
Primary 30 14.2
Secondary 119 56.1
College 44 20.8
Marital status Single 151 71.2
Married 55 25.9
Divorced 6 2.8
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Based on the mean score, and using similar score categor-
ies to the European study (<2 minimal stigma, 2-2.5 low
stigma, 2.5-3 moderate stigma, 3+ strong stigma) [32],
46.7% of participants had moderate or high stigma score.
Association of sociodemographic and clinical factors with
internalized stigma
The factors independently associated with higher inter-
nalized stigma score (moderate to high mean score)
were rural residence (OR = 5.67; 95% CI = 2.30, 13.00;
p < 0.001), single marital status (OR = 3.39; 95% CI =
1.40, 8.22; p = 0.019) and having prominent psychotic
symptoms (OR = 2.69; 95% CI = 1.36, 5.33; p = 0.004)
(Table 5). Although college education was associated
negatively with internalized stigma, this was not statisti-
cally significant (p = 0.057). However, lower internalized
stigma was associated with increasing levels of education
(Test for trend: Z = -2.07; P = 0.04). Rural residence,
single marital status and psychotic symptoms were also
important predictors of the individual stigma domains.
Education was significantly and negatively associated with
the domain of “stereotype endorsement” only (OR = 0.16;
95% CI = 0.16, 0.83; p = 0.016).
There was evidence of an association between a his-
tory of suicide attempt and high internalized stigma
score which persisted after adjusting for sex, age, reli-
gion, residence, employment and adherence to medica-
tion (OR 2.29; 95% CI 1.27, 4.11; p = 0.006). The
association between medication non-adherence and sui-
cide attempt was of borderline statistical significance
(OR 1.81; 95% CI 1.00, 3.27; p = 0.050). For those dis-
continuing their medication, stigma was the most im-
portant factor associated with discontinuation of their
medication (OR = 5.03; 95% CI = 1.98, 12.78; p = 0.001)
after controlling for the experience of extrapyramidal
side effects, educational status, symptom level, resi-
dence, employment, age and sex.
Discussion
Prevalence of internalized stigma
This study demonstrates the high burden of internalized
stigma among patients with schizophrenia attending a
specialist hospital in Ethiopia. Almost all participants
had experienced at least some level of internalized
stigma and about three-quarters endorsed strongly at
least one internalized stigma item. The experience of
stigma in each stigma domain was also high (50 to 72%)
with no significant difference within categories.
This is the first study in Ethiopia to investigate inter-
nalized stigma among patients with schizophrenia and
the second addressing the issue of stigma among
patients with schizophrenia. This study is also one of the
very few studies dealing with internalized stigma from
sub-Saharan Africa.
The current study replicates findings from previous
studies of stigma relating to mental illness from sub-
Saharan Africa [33-35] and Asia [36]. This study also
demonstrates that, in Ethiopia, the level of internalized
stigma experienced by patients with schizophrenia is
comparable to that of patients from Europe [32] across
all four internalized stigma domains (Table 4). From the
perspective of the mean score categories, at least a com-
parable proportion of our patients have moderate to
high stigma scores (46.7%) compared to patients from
Europe (41.7%) [32]. However, it may be argued that
participants in our study, coming predominantly from
Table 2 Clinical characteristics of participants
Variable name Total
N %
Total –––––– 212 100
Suicide attempt Yes 96 45.3
No 116 54.7
History of admission Yes 143 67.5
No 69 32.5
History of EPSE Yes 118 55.7
No 94 44.3
Medication non-adherence Yes 128 60.4
No 84 39.6
Contribution of stigma to non-adherence (N = 128)** Yes 62 48.4
No 66 51.6
Prominent psychotic symptoms Yes 68 32.1
No 144 67.9
Abbreviations: EPSE = Extrapyramidal side effects;
**Those without history of non-adherence (N = 84) excluded.
Assefa et al. BMC Psychiatry 2012, 12:239 Page 5 of 10
http://www.biomedcentral.com/1471-244X/12/239
urban areas, with a literacy rate of over 90% and a high
rate of treatment receipt (Table 1 and Table 2), are more
typical of patients with schizophrenia from Europe than
a low-income country. In Ethiopia only 16% of the
population lives in cities and towns [37], just 36% are
literate [38] and only about 10% of those with severe
mental disorders have a lifetime history of receipt of
treatment [39,40]. Nevertheless, in our study patients
coming from rural areas were more likely to have higher
stigma scores. Additionally, there was a trend for higher
levels of education (or more years in school) to be asso-
ciated with lower stigma score. Therefore, in this study
population, having characteristics commonly found
among patients from high-income settings (e.g., urban
Table 3 Factor loadings of the internalized stigma of mental illness scale based on principal components analysis and
varimax rotation method (values under .3 suppressed)
Stigma items Factors
Social
withdrawal
Perceived
discrimination
Alienation Stereotyped
endorsement
Out of place (I feel out of place in the world because I have a mental illness) .46
Spoiled life (Having a mental illness hasspoiled my life) .72
Others can’t understand (People without mental illness could not possibly
understand me)
.36 .53
Embarrassment (I am embarrassed or ashamed that I have a mental illness) .73
Disappointment (I am disappointed in myself for having a mental illness.) .74
Feel inferior (I feel inferior to others who don’t have a mental illness) .73
Stereotype belief (Stereotypes about the mentally ill apply to me) .32 .50
Known by looks (People can tell that I have a mental illness by the way I look) .32 .47
Violence (Mentally ill people tend to be violent) .58
Decisions (Because I have a mental illness, I need others to make most decisions
for me)
.31 .57
Rewarding Life (People with mental illness cannot live a good, rewarding life) .68
Marriage (Mentally ill people shouldn’tget married) .74
Contribution (I can’t contribute anything to society because I have a mental illness) .67
Discrimination (People discriminate against me because I have a mental illness) .70
Achievement (Others think that I can’t achieve much in life because I have a
mental illness)
.78
Ignored (People ignore me or take me less seriously just because I have a mental
illness)
.78
Patronized (People often patronize me, or treat me like a child, just because I have
a mental illness)
.76
People disinterested (Nobody would be interested in getting close to me because
I have a mental illness)
.64
Burden others (I don’t talk about myself much because I don’t want to burden
others with my mental illness)
–––– ––– ––– –––
Reduced socialisation (I don’t socialize as much as I used to because my mental
illness might make me look or behave "weird")
.79 –––
Isolated (Negative stereotypes against people with mental illness like myself keep
me isolated from the "normal" world)
.82
Protect family (I stay away from social situations in order to protect my family or
friends from embarrassment)
.71
Feel inadequate (Being around people who don’t have a mental illness makes me
feel out of place or inadequate)
.82
Rejection (I avoid getting close to people who don't have a mental illness to avoid
rejection )
.85
Eigen values 8.6 2.0 1.8 1.5
Percentage of total variance 16.7 14.1 13.9 12.4
Number of test variables 5 5 7 6
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residence and higher educational achievement) may in
fact confer a degree of protection against stigma. The
major limitation of this comparison is that the European
data is based on a much larger sample of participants
(n = 1229) from 14 European countries.
One of the explanations for the apparently
favourable outcome of schizophrenia in low-income
countries, is the presumed low prevalence of stigma
in these settings [41]. This assertion of improved out-
come in low-income settings has long been disputed
[42], yet even if it is accurate, the explanation for the
better outcome in low income settings is unlikely to
be related to low levels of stigma. There is now con-
sistent evidence to suggest that the level of stigma in
low income settings is at least as high as that found
in high income settings. The nature of stigma, as
shown in the ISMI sub-domains and factor analysis,
also appears consistent with that reported in European
studies [27-29].
Internalized stigma and possible impact upon the
recovery process
Findings from this study support the hypothesis that
stigma is an important obstacle in the recovery process.
Nearly half of all patients who were non-adherent to
their medication attributed their decision to discon-
tinue treatment to stigma. This group was predomin-
antly among those with higher level of stigma score.
Treatment adherence is the most important predictor
of positive outcome in severe mental disorders in low-
income countries [43,44]. Stigma may impact upon ad-
herence through various psychological mechanisms
such as loss of self-esteem and self-efficacy, de-
moralization, hopelessness and depression [4,28,45].
Stigma also leads to limited achievement of rehabilita-
tion goals such as living independently [46-49]. The
role of these factors is not assessed in this study but
would be of importance to do so in this setting.
Additionally we found that a higher stigma score was
associated robustly with a history of suicide attempt, an
important negative outcome of severe mental disorders.
Therefore, tackling stigma should be an important public
mental health intervention priority in low income coun-
tries. Strategies to address stigma should be incorporated
into initiatives to scale up mental health services in low
and middle-income countries [50].
Factors associated with internalized stigma
A higher level of internalized stigma was associated with
three factors: having rural residence, single marital status
and prominent psychotic symptoms. Rural residence has
been found previously to be associated with higher
stigma [51], and was attributed to lack of privacy and
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Figure 1 Proportion of patients with schizophrenia reporting internalized stigma experience according to the degree of endorsement
(agreement). ISMI = Internalized Stigma of Mental Illness.
Table 4 Comparison of mean scores of stigma domains
between patients with schizophrenia in Ethiopia and
Europe
Stigma domain Stigma score
Ethiopia Europe*
Mean SD Mean SD
Social withdrawal 2.4 0.9 2.4 0.6
Discrimination 2.5 0.7 2.4 0.6
Alienation 2.3 0.6 2.5 0.7
Stereotyped endorsement 2.5 0.6 2.1 0.5
* European data extracted from Brohan et al 2010 [29].
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anonymity in small rural communities. Such lack of
privacy and anonymity may have an impact on help
seeking, for example, by families attempting to hide the
patient away. This is particularly important in low in-
come settings where families play a key role in patients’
receipt of treatment.
The association of internalized stigma with psychotic
symptoms may be attributed to “reverse causality”.
Patients with higher levels of psychotic symptoms may
be more likely to perceive negative attitudes from others,
related to their psychopathology. On the other hand, un-
controlled symptoms may attract more attention to the
affected person and this may lead to discrimination.
There are two pathways in which uncontrolled symp-
toms may act as barriers to recovery: through reduced ad-
herence to treatment because of denial and fear of stigma,
and the psychological impact of stigma. Although not
robustly associated with internalized stigma, the trend in
this study is that education may be protective against
stigma, particularly stereotyped endorsement. Again this
is in line with findings of studies in other settings [52-54].
Limitations
The study design has inherent weaknesses, which were
difficult to avoid because of feasibility issues. The cross-
sectional design meant that it was not possible to infer
causality from the findings. The lack of longitudinal
analysis in relation to factors associated with interna-
lized stigma has been highlighted previously [55]. The
study setting and sample were not completely represen-
tative of the patient population with schizophrenia.
Only patients attending an out-patient service of a re-
ferral hospital participated in the study and those with
history of substance abuse were excluded. Patients who
were not fluent in Amharic were excluded due to lack
of interpreters. Patients with significant cognitive im-
pairment and impaired insight were also excluded.
These exclusions do reduce the generalisability of the
Table 5 Sociodemographic and clinical factors associated with moderate or high stigma scores (mean score of 2.5 and
above)
Variables N* Unadjusted model Fully adjusted model
OR 95% CI OR 95% CI P value
Sex Male 66/138 1.14 0.50 2.01 1.12 0.58 2.15 0.737
Female 33/74 Ref.
Marital status Single** 79/157 1.77 0.94 3.34 3.39 1.40 8.22 0.019
Married 20/55 Ref.
Education College graduate 18/44 075 0.37 1.52 0.44 0.19 1.02 0.057
Non-literate 11/19 1.50 0.56 3.98 1.47 0.43 5.06 0.539
Primary 13/30 0.83 0.37 1.86 1.16 0.45 2.98 0.756
Secondary 57/119 Ref.
Religion Moslem 20/51 0.71 0.36 1.38 0.59 0.26 1.35 0.210
Others 25/48 1.19 0.60 2.34 1.55 0.70 3.47 0.284
Orthodox 54/113 Ref.
Age (years) <25 13/30 0.99 0.33 2.97 0.54 1.15 2.03 0.365
25-34 43/89 1.22 0.48 3.06 0.77 0.17 1.69 0.633
35-44 33/70 1.16 0.45 2.99 0.71 0.23 1.88 0.543
≥45 10/23 Ref.
Residence Rural 31/43 3.84 1.84 8.00 5.67 2.30 13.00 <0.001
Urban 68/169 Ref.
Employment Unemployed 79/149 1.04 0.56 1.88 0.66 0.33 1.35 0.232
Employed 29/63 Ref.
Ethnicity Amhara 43/85 1.79 0.96 3.36 1.88 0.87 4.08 0.110
Oromo 28/50 2.23 1.08 4.60 1.73 0.75 4.01 0.201
Others 28/77 Ref.
Prominent psychotic symptoms Yes 68 2.17 1.19 3.93 2.69 1.36 5.33 0.004
No 144 Ref.
* = indicates number with moderate to high stigma/total in category.
** = includes 6 divorced individuals.
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findings. However, comparison with a previous report
describing the characteristics of patients admitted over
a one year period in the same specialist hospital as our
participants came from indicates general comparability
with patients being admitted [56]. Finally, some of the
outcomes were assessed with single questions, for ex-
ample treatment adherence and suicide attempt. The
question in relation to treatment adherence was close-
ended question and framed in a way that could have led
some patients to respond affirmatively.
Conclusions
This study suggests that a significant burden of stigma is
borne by patients with schizophrenia in Ethiopia. There
is sufficient data now from low-income countries to sug-
gest that a low prevalence of stigma cannot explain the
presumed favourable outcome of schizophrenia in low-
income countries. The current report, along with other
similar data from Ethiopia and other low-income coun-
tries, supports the need to incorporate culturally appro-
priate methods of addressing internalized stigma into
rehabilitation packages for this group. Particular atten-
tion should be paid to the potential for self-stigma to
inhibit help seeking and treatment adherence.
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